Drug Distribution Flashcards
Define zero- and first-order kinetics, and influence on half-life, volume of distribution and clearance of a drug
1st: A constant fraction of drug is removed constant clearance
•The time to remove the drug is independent of dose (if you increase [dose] the same fraction is removed) constant half-life
0: A constant amount of drug is removed
•The bigger the dose the longer the time to remove it
Vod; Total amount of drug / [Plasma] = Apparent volume of distribution (Vd)
•Indicates the extent of distribution for a drug
•Clinically important for adjusting dosage
•Influenced by lipid/water solubility, binding to plasma proteins
C; Describes activity of metabolising enzymes/excretion mechanisms Plasma clearance (CL): •Volume of plasma cleared of drug per time (ml min-1) •CL = Rate of elimination / [drug plasma] •A constant for 1st order reactions
Define bioavailability
Bioavailability : Fraction of drug in circulation compared to dose
Measures extent of absorption
Calculated by: Equal oral/iv doses, measure AUC oral / AUC iv
e.g. oral dose, F = 0.1 (10% bioavailability)
Describe factors that influence choice of drug route
Low bioavailability is caused by
Poor absorption
Chemical reactions at site of delivery
First-pass metabolism
•Choice of route guided by Bioavailability Chemical properties of drug Convenience Need to control specificity of action Desired onset/duration/offset of action
Discuss reasons for using different dosage regimen
Multiple dosing leads to a ‘steady state’
•Additional doses administered before [drug] falls to zero
•[Drug] variation depends on half-life and dose interval
•Multiple dose therapy compromises:
- minimisation of drug level variability
- simplicity
Describe the steady-state principle
-Idea of dosing regime is to balance:
Dosing rate = Rate of elimination
Dosing rate = Clearance x Css
Dosing rate x F = CL x Target Concentration
How to achieve steady state
- Repeated doses of drug eventually produce a steady state (plateau) concentration
- Time to plateau is 4-5 x drug half-life
- When dose is changed a new plateau is reached in 4-5 half-lives
- Steady state levels are not actually flat
- Fluctuation size is inversely proportional to the number of daily doses
- Fluctuations create the potential for sub-therapeutic treatment or toxicity
- For drugs with long half lives achievement of steady state can be accelerated by a loading dose